| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 77, 188-194, Copyright © 1993 by Endocrine Society
ARTICLES |
ML Casey, M Mibe and PC MacDonald
Cecil H. and Ida Green Center for Reproductive Biology Sciences, University of Texas Southwestern Medical Center, Dallas 75235-9051.
The regulation of PTH-related protein (PTH-rP) gene expression by human endometrial stromal cells in monolayer culture was evaluated. 17 beta- Estradiol (E2), interleukin-1 beta (IL-1 beta), tumor necrosis factor- alpha (TNF alpha), endothelin-1 (ET-1), transforming growth factor-beta 1 (TGF beta 1), and serum stimulated PTH-rP production (evaluated by immunoassay of PTH-rP in the culture medium) by these cells. Treatment of endometrial stromal cells with E2 plus a progestin, medroxy- progesterone acetate (MPA), caused a decrease in PTH-rP production. PRL, epidermal growth factor, and dexamethasone, which are known to affect PTH-rP production (increase or decrease) in other cells, were ineffective in altering PTH-rP production in endometrial stromal cells, as were a number of other growth factors, viz. TGF alpha, platelet- derived growth factor, and basic fibroblast growth factor, and metabolites of progesterone. The effects of E2 and MPA on PTH-rP gene expression in these cells were investigated in detail. E2 (50 nM) increased PTH-rP mRNA levels (at 2, 4, 8, 12, and 24 h). When serum (10%) was present in the medium, E2 (50 nM) did not increase PTH-rP production or PTH-rP mRNA levels, and in the presence of serum, E2 plus MPA did not decrease PTH-rP production. In cells that were pretreated with E2 (50 nM) for 48 h before treatment (18 h) with ET-1, TNF alpha, tetradecanoylphorbol acetate, and TGF beta 1, the production of PTH-rP was greater than that in cells not pretreated with estrogen. The effect of treatment of endometrial stromal cells with MPA on PTH-rP mRNA levels (at 2, 4, 8, and 12 h) was variable, but in all studies conducted, PTH-rP production after 18 or 24 h of progestin treatment was not increased compared with that in nontreated cells. We conclude that estrogen acts directly in endometrial stroma cells to increase PTH- rP mRNA levels and PTH-rP protein production. In addition IL-1 beta, TNF alpha, ET-1, TGF beta 1, and serum stimulate PTH-rP production by these cells. With the exception of serum, the effects of most of the other agents identified in this study to stimulate PTH-rP production were at least additive with that of E2.
This article has been cited by other articles:
![]() |
Y. Kinugasa, K.-i. Morishige, S. Kamiura, Y. Tsukamoto, and F. Saji Parathyroid Hormone-related Protein-Secreting Uterine Endometrioid Adenocarcinoma Jpn. J. Clin. Oncol., February 1, 2006; 36(2): 113 - 115. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.S. Thota, L.C. Reed, and C. Yallampalli Effects of Parathyroid Hormone Like Hormone (PTHLH) Antagonist, PTHLH7-34, on Fetoplacental Development and Growth During Midgestation in Rats Biol Reprod, December 1, 2005; 73(6): 1191 - 1198. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gessi, G. Monego, L. Lauriola, N. Maggiano, and F. O. Ranelletti Parathyroid Hormone-related Peptide (hPTHrP) and Parathyroid Hormone-related Peptide Receptor Type 1 (PTHR1) Expression in Human Thymus J. Histochem. Cytochem., August 1, 2005; 53(8): 955 - 962. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Bauersachs, S E Ulbrich, K Gross, S E M Schmidt, H H D Meyer, R Einspanier, H Wenigerkind, M Vermehren, H Blum, F Sinowatz, et al. Gene expression profiling of bovine endometrium during the oestrous cycle: detection of molecular pathways involved in functional changes J. Mol. Endocrinol., June 1, 2005; 34(3): 889 - 908. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Lindemann, P. Ballschmieter, A. Nordheim, and J. Dittmer Transforming Growth Factor beta Regulates Parathyroid Hormone-related Protein Expression in MDA-MB-231 Breast Cancer Cells through a Novel Smad/Ets Synergism J. Biol. Chem., November 30, 2001; 276(49): 46661 - 46670. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Garmey, J. A. Schnorr, M. E. Bruns, D. E. Bruns, R. M. Seaner, J. E. Ferguson II, F. C. Luking Jayes, C. Aguirre, and J. D. Veldhuis Expression of Parathyroid Hormone-Related Peptide (PTH-rp) and Its Receptorin the Porcine Ovary: Regulation by Transforming Growth Factor-{beta} and Possible Paracrine Effects of Granulosa Cell PTH-rp Secretion on Theca Cells Biol Reprod, February 1, 2000; 62(2): 334 - 339. [Abstract] [Full Text] |
||||
![]() |
R. A. Nowak, F. Haimovici, J. D. Biggers, and G. T. Erbach Transforming Growth Factor-ß Stimulates Mouse Blastocyst Outgrowth through a Mechanism Involving Parathyroid Hormone-Related Protein Biol Reprod, January 1, 1999; 60(1): 85 - 93. [Abstract] [Full Text] |
||||
![]() |
S.-i. Ozeki, A. Ohtsuru, S. Seto, S. Takeshita, H. Yano, T. Nakayama, M. Ito, T. Yokota, M. Nobuyoshi, G. V. Segre, et al. Evidence That Implicates the Parathyroid Hormone–Related Peptide in Vascular Stenosis : Increased Gene Expression in the Intima of Injured Rat Carotid Arteries and Human Restenotic Coronary Lesions Arterioscler Thromb Vasc Biol, April 1, 1996; 16(4): 565 - 575. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |